Gynecologic Cancer

Results of the Canadian Cancer Trials Group CX.5/SHAPE trial could lead to surgical de-escalation among patients with cervical cancer.

I lost my hair during cancer treatment, but now that it’s growing back, I no longer obviously look like a patient.

The benefit obtained from Keytruda plus chemotherapy in patients with persistent, recurrent or metastatic cervical cancer occurred regardless of whether they also received Avastin.

After going through cancer, Mother’s Day feels a bit different.

Patients with advanced or recurrent endometrial cancer derived a survival benefit from Jemperli plus chemotherapy.

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.

Researchers used an AI model to identify patients with endometrial cancer who had a low or high risk for cancer returning to another part of the body, also known as distant recurrence.

This analysis of the KEYNOTE-826 trial focused on health-related quality of life in patients with persistent, recurrent or metastatic cervical cancer.

Social media, including Facebook groups, can help connect patients with rare cancers like granulosa cell tumors to researchers, allowing them to learn more about disease management.

Interim findings from a clinical trial showed that adding Lynparza and Imfinzi to an Avastin and chemotherapy regimen tended to improve the time patients lived before their disease got worse.

Cryocompression was found to be tolerable and effective in preventing chemotherapy-induced peripheral neuropathy in a small study.

The Food and Drug Administration approved Keytruda for adult and pediatric patients with previously treated unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors.

The way I see it, double the cancer diagnoses means double the victory.

The phase 2 DESTINY-PanTumor02 trial included patients with HER2-expressing solid tumors such as bladder, pancreatic and rare tumors.

The first patient has been enrolled in a clinical trial evaluating IMNN-001, an immunotherapy, combined with Avastin for the treatment of advanced ovarian cancer.

On multiple occasions, doctors told me not to worry, but I ended up being diagnosed with a rare cancer called leiomyosarcoma.

Sometimes the steps I take leaving the hospital make me feel like I’m flying if I received good news, but other times, I’m walking quickly to my car before I begin to cry.

The hold has been placed due to visual side effects in a number of patients with solid tumors.

From education to second opinions, an expert offers tips to patients with cancer on self-advocacy, especially when it comes to fertility preservation.

The FDA granted a regular approval to patients with recurrent or advanced dMMR endometrial cancer.

Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead to lower quality of life after treatment.

When I started cancer treatment, I had been cast in some sci-fi flick without prior consent.

Findings from the phase 3 NRG-GY018 trial found that the addition of Keytruda to standard chemotherapy improved progression-free survival in patients with stage 3 to 4 or recurrent endometrial cancer.

Chemoradiotherapy may be an appropriate treatment option after surgery for patients with stage 3 endometrial cancer, especially those are a higher risk of recurrence.

From Tennis star Chris Evert’s cancer-free status to Duran Duran’s Andy Taylor talking about his prostate cancer, here’s what’s happening in the oncology space this week.